Global Inhalers & Nebulisers Market | CAGR 30.52%

The Global Inhalers & Nebulisers Market to grow from USD 58.71 Million in 2018 to USD 378.96 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 30.52%. Some of the major market players include Adherium Limited, AstraZeneca plc, GlaxoSmithKline plc, OPKO Health, Inc., and ResMed Inc.

360iResearch Logo
Global Inhalers & Nebulisers Market | CAGR 30.52%
Report Code: PH-DA05168 | Publishing Date: August 2019 | Number of Pages: 106
Global Inhalers & Nebulisers Market | CAGR 30.52%

Company Usability Profiles:

The global inhalers & nebulisers market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The global inhalers & nebulisers market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Adherium Limited
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • OPKO Health, Inc.
  • ResMed Inc
  • 3M Company
  • Boehringer Ingelheim group
  • Cohero Health, Inc.
  • Glenmark Pharmaceuticals
  • Novartis International AG
  • OMRON Healthcare Europe B.V
  • PARI GmbH
  • Sensirion AG Switzerland
  • Teva Pharmaceutical Industries Limited
  • Vectura Group plc

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Market Segmentation & Coverage:

The research report categorizes the Global Inhalers & Nebulisers Market to forecast the revenues and analyze the trends in each of the following segments:

  • GLOBAL INHALERS & NEBULISERS MARKET, BY PRODUCT
    • Inhalers
      • Dry Powder Inhalers
      • Metered Dose Inhalers
    • Nebulizers
  • GLOBAL INHALERS & NEBULISERS MARKET, BY INDICATION
    • Asthma
    • COPD
  • GLOBAL INHALERS & NEBULISERS MARKET, BY DISTRIBUTION MODE
    • Hospital pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • GLOBAL INHALERS & NEBULISERS MARKET, BY GEOGRAPHY
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Chile
      • Mexico
      • United States
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • South Korea
      • Thailand
    • Europe, Middle East & Africa
      • Denmark
      • France
      • Germany
      • Italy
      • Netherlands
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • United Arab Emirates
      • United Kingdom

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Global Inhalers & Nebulisers Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Global Inhalers & Nebulisers Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Global Inhalers & Nebulisers Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Global Inhalers & Nebulisers Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Global Inhalers & Nebulisers Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Global Inhalers & Nebulisers Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Global Inhalers & Nebulisers Market .
  • Evaluate the key vendors in the Global Inhalers & Nebulisers Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
      1. Research Process
      2. Research Framework
      3. Research Reliability & Validity
      4. Research Assumptions
    2. Forecasting Methodology
  3. Executive Summary
    1. Market Outlook
    2. Market Data Feed
  4. Premium Insight
    1. Market Connectivity
    2. Market Dynamics
      1. Drivers
        1. Increasing prevalence of people suffering from asthma and chronic obstructive pulmonary diseases
        2. Increasing adoption of digitally-improved products
        3. Digital Health partnerships between smart inhaler manufacturers and software companies
      2. Restraints
        1. Limited availability of smart inhalers
      3. Opportunities
        1. Technological advancements in smart inhaler devices and systems
        2. Growth opportunities in developing regions
      4. Challenges
        1. Higher cost associated with the development of smart inhalers
        2. Lack of reimbursement for smart inhalers
    3. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    4. Client Customizations
      1. Patent Analysis & Trend
  5. Global Inhalers & Nebulisers Market, by Product
    1. Overview
    2. Market Sizing & Forecasting
    3. Inhalers
      1. Dry Powder Inhalers
      2. Metered Dose Inhalers
    4. Nebulizers
  6. Global Inhalers & Nebulisers Market, by Indication
    1. Overview
    2. Market Sizing & Forecasting
    3. Asthma
    4. COPD
  7. Global Inhalers & Nebulisers Market, by Distribution Mode
    1. Overview
    2. Market Sizing & Forecasting
    3. Hospital pharmacies
    4. Online Pharmacies
    5. Retail Pharmacies
  8. Global Inhalers & Nebulisers Market, by Geography
    1. Overview
    2. Market Sizing & Forecasting
    3. Americas
      1. Argentina
      2. Brazil
      3. Canada
      4. Chile
      5. Mexico
      6. United States
    4. Asia-Pacific
      1. Australia
      2. China
      3. India
      4. Indonesia
      5. Japan
      6. Malaysia
      7. Philippines
      8. South Korea
      9. Thailand
    5. Europe, Middle East & Africa
      1. Denmark
      2. France
      3. Germany
      4. Italy
      5. Netherlands
      6. Qatar
      7. Russia
      8. Saudi Arabia
      9. South Africa
      10. Spain
      11. United Arab Emirates
      12. United Kingdom
  9. Competitive Landscape
    1. FPNV Positioning Matrix
      1. Quadrants
        1. Forefront
        2. Pathfinders
        3. Niche
        4. Vital
      2. Business Strategy
        1. Business Growth
        2. Industry Coverage
        3. Financial Viability
        4. Channel Support
      3. Product Satisfaction
        1. Value for Money
        2. Ease of Use
        3. Product Features
        4. Customer Support
    2. Market Vendor Ranking Analysis
    3. Competitive News Feed Analysis
  10. Company Usability Profiles
    1. Adherium Limited
      1. Overview
      2. Strategy
      3. SWOT
    2. AstraZeneca plc
      1. Overview
      2. Strategy
      3. SWOT
    3. GlaxoSmithKline plc
      1. Overview
      2. Strategy
      3. SWOT
    4. OPKO Health, Inc.
      1. Overview
      2. Strategy
      3. SWOT
    5. ResMed Inc
      1. Overview
      2. Strategy
      3. SWOT
    6. 3M Company
    7. Boehringer Ingelheim group
    8. Cohero Health, Inc.
    9. Glenmark Pharmaceuticals
    10. Novartis International AG
    11. OMRON Healthcare Europe B.V
    12. PARI GmbH
    13. Sensirion AG Switzerland
    14. Teva Pharmaceutical Industries Limited
    15. Vectura Group plc
  11. Appendix
    1. Discussion Guide
    2. Author Details

List of Tables

  1. GLOBAL INHALERS & NEBULISERS MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL INHALERS & NEBULISERS MARKET SIZE, 2016-2025 (USD MILLION)
  3. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  4. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY INHALERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  5. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY DRY POWDER INHALERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  6. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY METERED DOSE INHALERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  7. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY NEBULIZERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  8. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  9. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY ASTHMA, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  10. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY COPD, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  11. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  12. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  13. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  14. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  15. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  16. AMERICAS INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  17. AMERICAS INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  18. AMERICAS INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  19. ARGENTINA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  20. ARGENTINA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  21. ARGENTINA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  22. BRAZIL INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  23. BRAZIL INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  24. BRAZIL INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  25. CANADA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  26. CANADA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  27. CANADA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  28. CHILE INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  29. CHILE INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  30. CHILE INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  31. MEXICO INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  32. MEXICO INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  33. MEXICO INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  34. UNITED STATES INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  35. UNITED STATES INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  36. UNITED STATES INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  37. ASIA-PACIFIC INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  38. ASIA-PACIFIC INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  39. ASIA-PACIFIC INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  40. AUSTRALIA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  41. AUSTRALIA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  42. AUSTRALIA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  43. CHINA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  44. CHINA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  45. CHINA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  46. INDIA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  47. INDIA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  48. INDIA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  49. INDONESIA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  50. INDONESIA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  51. INDONESIA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  52. JAPAN INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  53. JAPAN INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  54. JAPAN INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  55. MALAYSIA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  56. MALAYSIA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  57. MALAYSIA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  58. PHILIPPINES INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  59. PHILIPPINES INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  60. PHILIPPINES INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  61. SOUTH KOREA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  62. SOUTH KOREA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  63. SOUTH KOREA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  64. THAILAND INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  65. THAILAND INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  66. THAILAND INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  67. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  68. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  69. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  70. DENMARK INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  71. DENMARK INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  72. DENMARK INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  73. FRANCE INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  74. FRANCE INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  75. FRANCE INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  76. GERMANY INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  77. GERMANY INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  78. GERMANY INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  79. ITALY INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  80. ITALY INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  81. ITALY INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  82. NETHERLANDS INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  83. NETHERLANDS INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  84. NETHERLANDS INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  85. QATAR INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  86. QATAR INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  87. QATAR INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  88. RUSSIA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  89. RUSSIA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  90. RUSSIA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  91. SAUDI ARABIA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  92. SAUDI ARABIA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  93. SAUDI ARABIA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  94. SOUTH AFRICA INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  95. SOUTH AFRICA INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  96. SOUTH AFRICA INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  97. SPAIN INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  98. SPAIN INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  99. SPAIN INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  100. UNITED ARAB EMIRATES INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  101. UNITED ARAB EMIRATES INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  102. UNITED ARAB EMIRATES INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  103. UNITED KINGDOM INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  104. UNITED KINGDOM INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2016-2025 (USD MILLION)
  105. UNITED KINGDOM INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2016-2025 (USD MILLION)
  106. GLOBAL INHALERS & NEBULISERS MARKET: RANKING
  107. GLOBAL INHALERS & NEBULISERS MARKET: AUTHOR DETAILS

List of Figures

  1. GLOBAL INHALERS & NEBULISERS MARKET: RESEARCH PROCESS
  2. GLOBAL INHALERS & NEBULISERS MARKET: RESEARCH FRAMEWORK
  3. GLOBAL INHALERS & NEBULISERS MARKET: FORECASTING METHODOLOGY
  4. GLOBAL INHALERS & NEBULISERS MARKET SIZE, 2016-2025 (USD MILLION)
  5. GLOBAL INHALERS & NEBULISERS MARKET: MARKET CONNECTIVITY
  6. GLOBAL INHALERS & NEBULISERS MARKET: MARKET DYNAMICS
  7. GLOBAL INHALERS & NEBULISERS MARKET: PORTERS FIVE FORCES ANALYSIS
  8. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2018 VS 2025 (USD MILLION)
  9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY PRODUCT, 2025 (USD MILLION)
  10. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2018 VS 2025 (USD MILLION)
  11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY INDICATION, 2025 (USD MILLION)
  12. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2018 VS 2025 (USD MILLION)
  13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY DISTRIBUTION MODE, 2025 (USD MILLION)
  14. GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INHALERS & NEBULISERS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  16. GLOBAL INHALERS & NEBULISERS MARKET: FPNV POSITIONING MATRIX
  17. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL INHALERS & NEBULISERS MARKET, BY NEWS TYPE
  18. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL INHALERS & NEBULISERS MARKET, BY COMPANY
  19. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL INHALERS & NEBULISERS MARKET, BY YEAR
  1. Adherium Limited
  2. AstraZeneca plc
  3. GlaxoSmithKline plc
  4. OPKO Health, Inc.
  5. ResMed Inc
  6. 3M Company
  7. Boehringer Ingelheim group
  8. Cohero Health, Inc.
  9. Glenmark Pharmaceuticals
  10. Novartis International AG
  11. OMRON Healthcare Europe B.V
  12. PARI GmbH
  13. Sensirion AG Switzerland
  14. Teva Pharmaceutical Industries Limited
  15. Vectura Group plc
Global Inhalers & Nebulisers Market
Report Code
PH-DA05168
Publishing Date
August 2019
Number of Pages
106
Available Formats

SELECT LICENSE TYPE

ENTERPRISE USER LICENSE $5449
CORPORATE USER LICENSE $4449
SINGLE USER LICENSE $3449
WEB PACK LICENSE $2949
DATA PACK LICENSE $1749

Trusted by 2,000+ Companies Worldwide

Here's what some of our customers say about our work.
We appreciate all of our customers' testimonials.